Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Argraves KM et al. | S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. | 2011 | Lipids Health Dis | pmid:21554699 |
Baranowski M et al. | Exercise increases plasma levels of sphingoid base-1 phosphates in humans. | 2011 | Acta Physiol (Oxf) | pmid:21535416 |
Sánchez BA et al. | Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. | 2011 | Anal Bioanal Chem | pmid:21394454 |
Yonamine I et al. | Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors. | 2011 | J. Cell Biol. | pmid:21321100 |
Cutignano A et al. | UPLC-MS/MS method for analysis of sphingosine 1-phosphate in biological samples. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20601074 |
Park SW et al. | Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. | 2010 | Lab. Invest. | pmid:20458275 |
Bu S et al. | Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels. | 2010 | Arthritis Rheum. | pmid:20309867 |
Knapp M et al. | Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction. | 2009 | Med. Sci. Monit. | pmid:19721401 |
Scherer M et al. | High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. | 2009 | Clin. Chem. | pmid:19325012 |
Berdyshev EV et al. | FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. | 2009 | J. Biol. Chem. | pmid:19119142 |